Jacob Schachter

机构：Sheba Medical Center · ORCID：0000-0001-8674-6476

发表论文 439 篇 · 总被引 31821 次 · h-index 65

代表论文

Randomized, double-blind, phase III LEAP-003 study of first-line lenvatinib plus pembrolizumab versus placebo plus pembrolizumab for unresectable or metastatic melanoma (2025 · Annals of Oncology · 被引 8)
Immune Checkpoint Inhibitors in the Treatment of Advanced Melanoma in Older Patients: An Overview of Published Data (2025 · Cancers · 被引 7)
Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma (2025 · Annals of Oncology · 被引 7)
Anti-4CB1: A Novel Selective HVEM-Blocking Antibody Enhancing T-Cell and Macrophage Immunity Against Solid Tumors (2026 · Molecular Cancer Therapeutics)
Supplementary Figure 2 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2 (2025)
Supplementary Figure 3 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2 (2025)